Get startedLog in
    Picture of SciClone Pharmaceuticals (Holdings) logo

    6600 — SciClone Pharmaceuticals (Holdings) News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: SciClone Pharmaceuticals Announces License And Collaboration Deal For Vaborem In China

    Picture of SciClone Pharmaceuticals (Holdings) logoSciClone Pharmaceuticals (Holdings)
    15/08/2022 07:42
    Aug 15 (Reuters) - SciClone Pharmaceuticals (Holdings) Ltd
 6600.HK :
    * SCICLONE AND MENARINI ESTABLISH LICENSE AND COLLABORATION
AGREEMENT FOR VABOREM IN CHINA
    * LICENSE AGREEMENT GRANTS GROUP EXCLUSIVE RIGHT TO DEVELOP
AND
COMMERCIALIZE VABOREM IN CHINA

Source text for Eikon:  ID:nHKS1l03SX 
Further company coverage:  6600.HK 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on SciClone Pharmaceuticals (Holdings)

    See all news